Lawyers for millionaire murderer John E. du Pont are urging a federal appeals court to order hearings on the issue of whether the defense lawyers in his 1997 trial effectively botched the defense by failing to focus on du Pont’s use of a Bulgarian prescription drug that may have exacerbated his mental illness.

Du Pont received a setback last week when a three-judge panel of the 3rd U.S. Circuit Court of Appeals announced that it will not hear oral arguments in the case.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]